NasdaqCM - Delayed Quote USD

Inspira Technologies Oxy B.H.N. Ltd. (IINN)

Compare
1.3700 -0.0300 (-2.14%)
At close: 4:00 PM EDT
1.4300 +0.06 (+4.38%)
After hours: 4:23 PM EDT
Loading Chart for IINN
DELL
  • Previous Close 1.4000
  • Open 1.4200
  • Bid 1.3300 x 100
  • Ask 1.4400 x 100
  • Day's Range 1.3500 - 1.4491
  • 52 Week Range 0.7610 - 2.4900
  • Volume 171,565
  • Avg. Volume 110,487
  • Market Cap (intraday) 25.35M
  • Beta (5Y Monthly) 2.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure. Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

inspira-technologies.com

37

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IINN

View More

Performance Overview: IINN

Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IINN
29.25%
S&P 500
20.57%

1-Year Return

IINN
0.00%
S&P 500
35.98%

3-Year Return

IINN
49.45%
S&P 500
31.99%

5-Year Return

IINN
72.60%
S&P 500
31.47%

Compare To: IINN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IINN

View More

Valuation Measures

Annual
As of 10/3/2024
  • Market Cap

    25.53M

  • Enterprise Value

    22.74M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    4.78

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -59.53%

  • Return on Equity (ttm)

    -116.54%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -11.29M

  • Diluted EPS (ttm)

    -0.7800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.36M

  • Total Debt/Equity (mrq)

    15.30%

  • Levered Free Cash Flow (ttm)

    -4.74M

Research Analysis: IINN

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: IINN

People Also Watch